This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Sinus Therapeutic Drugs Market

Market Insights on Sinus Therapeutic Drugs covering sales outlook, demand forecast & up-to-date key trends

Sinus Therapeutic Drugs Market By Route of Administration (Oral, Topical, Injectable), Disease Type (Acute Sinusitis, Sub-acute Sinusitis, Chronic Sinusitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Region - Forecast to 2020-2030

Sinus Therapeutic Drugs Market Outlook and Key Findings

  • The global sinus therapeutics drugs market is expected to witness a CAGR of over 6.3% between 2020 and 2030
  • North America and Europe collectively account for more than 50% of market share and this scenario is expected to persist in the forecast period as well.
  • Asia-Pacific is expected to grow at the fastest pace by 2030
  • Oral route of administration remains the preferred course of treatment.
Customize this Report

Let us know your requirement to get
100% FREE customization

Market Snapshot

Majority of sinus infections are reported to be caused by common cold and viral infections. These infections are classified as chronic and acute based on severity.

The chronic ones are those lasting for more than 3 months. Acute sinusitis get cured within 30 days.

At preliminary stage, sinus infections get diagnosed by physically inspecting characteristics of nasal mucosa, nasal septum’s structure, and presence of polyps.

At times, even imaging procedures like MRI (Magnetic Resonance Imaging), ultrasound, and CT (computed tomography) could be used to gauge the severity.

The commonly prescribed sinus therapeutic drugs include painkillers, corticosteroids, sulfonamides, antibiotics, and antihistamines.

The antibiotics used for treating bacterial infections herein include cephalospotin’s, penicillin, and macrolides.

Prednisone, triamcinolone, fluticasone, and mometastone are amongst the corticosteroids used to treat sinus infections. Sulfa drugs are inclusive of trimethoprim and sulfamethoxazole.

Antibiotics are expected to witness exponentiation in the forecast period. This could be attributed to diagnostic technologies being developed post introducing rapid microbial tests.

Besides, market players are looking for expansion in the markets of Asia-Pacific like Indonesia, Philippines, China, and India. This trend is expected to boost the market during the forecast period.

The other treatment options include bacterial lysates, capsaicin, anti-IL5, anti-IgE, and antifungals

Innovations & Regulatory Approvals to be a Key Growth Factor

The sinus therapeutic drugs market players are treading the innovative path followed by approvals to table their superiority. These measures are bound to give impetus to the market during the forecast period.

For instance –

  • In Aug 2020, Xolair (omalizumab) from Novartis obtained approval from the European Commission in the form of an add-on therapy along with corticosteroids for treating chronic rhinosinusitis with the nasal polyps.
  • In Aug 2020, Satsuma Pharmaceuticals, Inc. announced initiation on the part of enrolment of patients in ASCEND trial – a multi-centre, 12-month, open-label study for evaluating tolerability and safety of STS101 (dihydroergotamine (DHE) nasal powder) in the form of acute treatment with respect to migraine.
  • In Aug 2020, Bryn Pharma reported to have raised US$ 11 Mn to enable advancement in Bi-Dose Epinephrine nasal spray to cure Anaphylaxis
  • In May 2020, Ondine Biomedical Inc. announced reception of CE mark with respect to its broad-spectrum non-antibiotic nasal decolonization therapy
  • In Jan 2020, Valtoco (diazepam nasal spray) was approved by the US FDA for treating cluster seizures. This type of medicine is generally referred to as “rescue therapy”
  • In Jan 2020, Lyra Therapeutics, Inc. announced that the US FDA had cleared its IND (Investigational New Drug) application regarding LYR-210 for treating CRS (chronic rhinosinusitis)
  • In Jan 2020, Lannett Company, Inc. announced approval by the US FDA to market “Numbrino”, one of the topical solutions for mucus membranes in nasal cavities.
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Covid-19 Impact

The ongoing pandemic has compelled the sinus therapeutic drugs market players to speed up the production of drugs to address it, as it is a known fact that disorders in respiratory track can increase the risk of contraction.

For instance –

  • In Aug 2020, Atossa Therapeutics obtained approval from the US FDA for starting with AT-301 nasal spray’s clinical study. This nasal spray is being developed to combat Covid-19.
  • In Jul 2020, CEBINA GmBh announced positive results regarding Covid-19 drug repurposing project by identifying commonly used drugs that have been approved before against SARS-CoV-2 infection in the in-vitro assays. Azelastine is one such nasal spray.

Since the last few months, Aviptaadil Covid-19 therapeutic has been treating critical Covid-19.

Sinus Therapeutic Drugs Market: Region-Wise Analysis

Sinus Therapeutic Drugs Market Download Report Brochure

Traditionally, the US and Western European countries have remained the most lucrative markets for sinus therapeutic drug manufacturers. The scenario is likely to witness significant change during the forecast period, as many countries in Asia Pacific are offering lucrative opportunities.

The Asia Pacific sinus therapeutics drugs market is likely to grow at the fastest pace in the forecast period, as the players are expanding in this region, and some of them are also reported to shift their base over here.

Moreover, many countries in Asia Pacific have world’s worst air quality, and respiratory disorders have witnessed a rapid spike, with rise in industrialization.

Sinus Therapeutic Drugs Market Players

The market players are launching new products to stand out as differentiators. This strategy is being emphasized on, and has kept the users guessing, regarding novelty.

For instance –

  • Recently, Janssen submitted Esketamine Nasal Spray novel drug application to the US FDA to restore connections between neural cells in those suffering from depression.
  • In Feb 2019, Fresenius Kabi introduced Methocarbamol injection to be available all across the US to address musculoskeletal pain resulting out of respiratory disorders.
  • In Jan 2019, Dr. Reddy’s Laboratories Ltd., along with Promius Pharma LLC announced approval of TOSYMRA to treat acute migraine.

The major players in the sinus therapeutic drug market include:

  • Sun Pharmaceutical Industries, Inc.
  • Reddy’s Laboratories, Inc.
  • Novartis AG
  • Tea Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Fresenius Kabi USA
  • Janssen Pharmaceuticals, Inc.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sinus Therapeutic Drugs Market: The Way Forward

The global sinus therapeutic drugs market is expected to witness a substantial CAGR of over 6.3% between 2020 and 2030. The onslaught of Covid-19 has resulted in increase in production of these drugs as it is directly related to disorders in the nasal tract.

The market players, though vying for innovation, should also think more from the inorganic growth perspective. As such, they should be looking forward to go for mergers, acquisitions, partnerships, joint ventures to be able to reach out to a broader audience.

Key Segment

Route of Administration

  • Oral
  • Topical
  • Injectable

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Disease Type

  • Acute Sinusitis
  • Sub-acute Sinusitis
  • Chronic Sinusitis

Geography

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

The sinus therapeutic drugs market is likely to secure a CAGR of 4% through 2032.

The sinus therapeutic drugs market size is estimated to cross US$ 6.35 Bn by 2032.

The sinus therapeutic drugs market is likely to record a value of US$ 4.29 Bn in 2022.

US is likely to lead the sinus therapeutic drugs market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Drug Development Trends

4. Key Success Factors

    4.1. Adoption Analysis of Sinus Therapeutic Drugs

    4.2. Regulatory Scenario

    4.3. Reimbursement Scenario

    4.4. Pipeline Analysis

    4.5. Key Promotional Strategies, By Manufacturers

5. Sinus Therapeutic Drug Market Demand (Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    5.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    5.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Global GDP Growth Outlook

        6.1.2. Per Capita Healthcare Expenditure Outlook

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. Growing Prevalence of Severe Allergic Asthma

        6.2.2. Cost of Sinus Therapeutic Drug

        6.2.3. Consolidation of Healthcare Industry

        6.2.4. Increase in Patient Pool

    6.3. Value Chain

    6.4. Market Dynamics

        6.4.1. Drivers

        6.4.2. Restraints

        6.4.3. Opportunity Analysis

    6.5. COVID19 Crisis Analysis

        6.5.1. Current COVID19 Statistics and Probable Future Impact

        6.5.2. Current GDP Projection and Probable Impact

        6.5.3. Current Economic Projection as compared to 2008 Economic analysis

        6.5.4. COVID19 and Impact Analysis

            6.5.4.1. Revenue By Drug Class

            6.5.4.2. Revenue By Disease Type

            6.5.4.3. Revenue By Route of Administration

            6.5.4.4. Revenue By Distribution Channel

            6.5.4.5. Revenue By Country

        6.5.5. 2020 Market Scenario

        6.5.6. Quarter by Quarter Forecast

        6.5.7. Projected recovery Quarter

        6.5.8. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Drug Class

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) By Drug Class, 2015-2019

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2020-2030

        7.3.1. Аntіhіѕtаmіnеѕ

        7.3.2. Аnаlgеѕісѕ

        7.3.3. Ѕulрhоnаmіdеѕ

        7.3.4. Соrtісоѕtеrоіdѕ

        7.3.5. Аntіbіоtісѕ

        7.3.6. NSAID’s

        7.3.7. Оthеr Drug Сlаѕѕеѕ

    7.4. Market Attractiveness Analysis By Drug Class

8. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Disease Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) By Disease Type, 2015-2019

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2020-2030

        8.3.1. Асutе Sіnuѕіtіѕ

        8.3.2. Ѕub-асutе Sіnuѕіtіѕ

        8.3.3. Сhrоnіс Sіnuѕіtіѕ 

    8.4. Market Attractiveness Analysis By Disease Type

9. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015-2019

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2020-2030

        9.3.1. Oral

        9.3.2. Topical

        9.3.3. Injectable

    9.4. Market Attractiveness Analysis By Route of Administration

10. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030

        10.3.1. Ноѕріtаl Рhаrmасіеѕ

        10.3.2. Rеtаіl Рhаrmасіе

        10.3.3. Оnlіnе Рhаrmасіеѕ

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        12.3.1.  By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Drug Class

        12.3.3. By Disease Type

        12.3.4. By Route of Administration

        12.3.5. By Distribution Channel

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        13.3.1.  By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Drug Class

        13.3.3. By Disease Type

        13.3.4. By Route of Administration

        13.3.5. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030

        14.3.1.  By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Drug Class

        14.3.3. By Disease Type

        14.3.4. By Route of Administration

        14.3.5. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. South Asia Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030

        15.3.1.  By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Drug Class

        15.3.3. By Disease Type

        15.3.4. By Route of Administration

        15.3.5. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        16.3.1.  By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Drug Class

        16.3.3. By Disease Type

        16.3.4. By Route of Administration

        16.3.5. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        17.3.1.  By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Drug Class

        17.3.3. By Disease Type

        17.3.4. By Route of Administration

        17.3.5. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        18.3.1.  By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4. Rest of Middle East and Africa

        18.3.2. By Drug Class

        18.3.3. By Disease Type

        18.3.4. By Route of Administration

        18.3.5. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. U.S. Sinus Therapeutic Drug Market Analysis

        19.2.1. By Drug Class

        19.2.2. By Disease Type

        19.2.3. By Route of Administration

        19.2.4. By Distribution Channel

    19.3. Canada Sinus Therapeutic Drug Market Analysis

        19.3.1. By Drug Class

        19.3.2. By Disease Type

        19.3.3. By Route of Administration

        19.3.4. By Distribution Channel

    19.4. Mexico Sinus Therapeutic Drug Market Analysis

        19.4.1. By Drug Class

        19.4.2. By Disease Type

        19.4.3. By Route of Administration

        19.4.4. By Distribution Channel

    19.5. Brazil Sinus Therapeutic Drug Market Analysis

        19.5.1. By Drug Class

        19.5.2. By Disease Type

        19.5.3. By Route of Administration

        19.5.4. By Distribution Channel

    19.6. U.K. Sinus Therapeutic Drug Market Analysis

        19.6.1. By Drug Class

        19.6.2. By Disease Type

        19.6.3. By Route of Administration

        19.6.4. By Distribution Channel

    19.7. Germany Sinus Therapeutic Drug Market Analysis

        19.7.1. By Drug Class

        19.7.2. By Disease Type

        19.7.3. By Route of Administration

        19.7.4. By Distribution Channel

    19.8. France Sinus Therapeutic Drug Market Analysis

        19.8.1. By Drug Class

        19.8.2. By Disease Type

        19.8.3. By Route of Administration

        19.8.4. By Distribution Channel

    19.9. Italy Sinus Therapeutic Drug Market Analysis

        19.9.1. By Drug Class

        19.9.2. By Disease Type

        19.9.3. By Route of Administration

        19.9.4. By Distribution Channel

    19.10. Spain Sinus Therapeutic Drug Market Analysis

        19.10.1. By Drug Class

        19.10.2. By Disease Type

        19.10.3. By Route of Administration

        19.10.4. By Distribution Channel

    19.11. BENELUX Sinus Therapeutic Drug Market Analysis

        19.11.1. By Drug Class

        19.11.2. By Disease Type

        19.11.3. By Route of Administration

        19.11.4. By Distribution Channel

    19.12. Russia Sinus Therapeutic Drug Market Analysis

        19.12.1. By Drug Class

        19.12.2. By Disease Type

        19.12.3. By Route of Administration

        19.12.4. By Distribution Channel

    19.13. China Sinus Therapeutic Drug Market Analysis

        19.13.1. By Drug Class

        19.13.2. By Disease Type

        19.13.3. By Route of Administration

        19.13.4. By Distribution Channel

    19.14. Japan Sinus Therapeutic Drug Market Analysis

        19.14.1. By Drug Class

        19.14.2. By Disease Type

        19.14.3. By Route of Administration

        19.14.4. By Distribution Channel

    19.15. South Korea Sinus Therapeutic Drug Market Analysis

        19.15.1. By Drug Class

        19.15.2. By Disease Type

        19.15.3. By Route of Administration

        19.15.4. By Distribution Channel

    19.16. India Sinus Therapeutic Drug Market Analysis

        19.16.1. By Drug Class

        19.16.2. By Disease Type

        19.16.3. By Route of Administration

        19.16.4. By Distribution Channel

    19.17. Australia Sinus Therapeutic Drug Market Analysis

        19.17.1. By Drug Class

        19.17.2. By Disease Type

        19.17.3. By Route of Administration

        19.17.4. By Distribution Channel

    19.18. New Zealand Sinus Therapeutic Drug Market Analysis

        19.18.1. By Drug Class

        19.18.2. By Disease Type

        19.18.3. By Route of Administration

        19.18.4. By Distribution Channel

    19.19. GCC Countries Sinus Therapeutic Drug Market Analysis

        19.19.1. By Drug Class

        19.19.2. By Disease Type

        19.19.3. By Route of Administration

        19.19.4. By Distribution Channel

    19.20. Turkey Sinus Therapeutic Drug Market Analysis

        19.20.1. By Drug Class

        19.20.2. By Disease Type

        19.20.3. By Route of Administration

        19.20.4. By Distribution Channel

    19.21. South Africa Sinus Therapeutic Drug Market Analysis

        19.21.1. By Drug Class

        19.21.2. By Disease Type

        19.21.3. By Route of Administration

        19.21.4. By Distribution Channel

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Concentration

    20.3. Market Share Analysis of Top Players

    20.4. Market Presence Analysis

        20.4.1. By Regional footprint of Players

        20.4.2. Product foot print by Players

        20.4.3. Channel Foot Print by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. AstraZeneca

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.1.4. Sales Footprint

            21.3.1.5. Strategy Overview

                21.3.1.5.1. Marketing Strategy

                21.3.1.5.2. Product Strategy

                21.3.1.5.3. Channel Strategy

        21.3.2. Bausch Health

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.2.4. Sales Footprint

            21.3.2.5. Strategy Overview

                21.3.2.5.1. Marketing Strategy

                21.3.2.5.2. Product Strategy

                21.3.2.5.3. Channel Strategy

        21.3.3. Nоvаrtіѕ АG

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.3.4. Sales Footprint

            21.3.3.5. Strategy Overview

                21.3.3.5.1. Marketing Strategy

                21.3.3.5.2. Product Strategy

                21.3.3.5.3. Channel Strategy

        21.3.4. Ѕun Рhаrmасеutісаl Іnduѕtrіеѕ, Іnс

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.4.4. Sales Footprint

            21.3.4.5. Strategy Overview

                21.3.4.5.1. Marketing Strategy

                21.3.4.5.2. Product Strategy

                21.3.4.5.3. Channel Strategy

        21.3.5. Rеddу'ѕ Lаbоrаtоrіеѕ, Іnс.

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.5.4. Sales Footprint

            21.3.5.5. Strategy Overview

                21.3.5.5.1. Marketing Strategy

                21.3.5.5.2. Product Strategy

                21.3.5.5.3. Channel Strategy

        21.3.6. Теа Рhаrmасеutісаl Іnduѕtrіеѕ Ltd.

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.6.4. Sales Footprint

            21.3.6.5. Strategy Overview

                21.3.6.5.1. Marketing Strategy

                21.3.6.5.2. Product Strategy

                21.3.6.5.3. Channel Strategy

        21.3.7. Frеѕеnіuѕ Каbі UЅА

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.7.4. Sales Footprint

            21.3.7.5. Strategy Overview

                21.3.7.5.1. Marketing Strategy

                21.3.7.5.2. Product Strategy

                21.3.7.5.3. Channel Strategy

        21.3.8. Јоhnѕоn & Јоhnѕоn

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.8.4. Sales Footprint

            21.3.8.5. Strategy Overview

                21.3.8.5.1. Marketing Strategy

                21.3.8.5.2. Product Strategy

                21.3.8.5.3. Channel Strategy

        21.3.9. Рfіzеr Іnс

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.9.4. Sales Footprint

            21.3.9.5. Strategy Overview

                21.3.9.5.1. Marketing Strategy

                21.3.9.5.2. Product Strategy

                21.3.9.5.3. Channel Strategy

        21.3.10. Јаnѕѕеn Рhаrmасеutісаlѕ, Іnс.

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.10.4. Sales Footprint

            21.3.10.5. Strategy Overview

                21.3.10.5.1. Marketing Strategy

                21.3.10.5.2. Product Strategy

                21.3.10.5.3. Channel Strategy

        21.3.11. GlaxoSmithKline plc

            21.3.11.1. Overview

            21.3.11.2. Product Portfolio

            21.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.11.4. Sales Footprint

            21.3.11.5. Strategy Overview

                21.3.11.5.1. Marketing Strategy

                21.3.11.5.2. Product Strategy

                21.3.11.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Drug Class

Table 02: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Disease Type

Table 03: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Route of Administration

Table 04: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Distribution Channel

Table 05: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region

Table 06: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 07: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 08: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type

Table 09: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration

Table 10: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 11: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 12: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 13: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type

Table 14: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration

Table 15: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 16: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 17: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 18: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type

Table 19: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration

Table 20: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 21: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 22: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 23: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type

Table 24: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration

Table 25: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 26: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 27: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 28: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type

Table 29: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration

Table 30: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 31: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 32: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 33: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type

Table 34: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration

Table 35: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 36: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 37: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 38: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type

Table 39: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration

Table 40: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Sinus Therapeutic Drug Market Value Share, By Drug Class, 2019 (A)

Figure 02: Global Sinus Therapeutic Drug Market Value Share, By Disease Type, 2019 (A)

Figure 03: Global Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2019 (A)

Figure 04: Global Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2019 (A)

Figure 05: Global Sinus Therapeutic Drug Market Value Analysis 2015-2019 & 2020-2030

Figure 06: Global Sinus Therapeutic Drug Market Y-O-Y Growth Analysis By Region

Figure 07: Global Sinus Therapeutic Drug Market Value Analysis and Forecast, 2020–2030 (US$ Mn)

Figure 08: Global Sinus Therapeutic Drug Market Absolute $ Opportunity (US$ Mn), 2015–2019

Figure 09: Global Sinus Therapeutic Drug Market Absolute $ Opportunity (US$ Mn), 2020–2030

Figure 10: Global Sinus Therapeutic Drug Market Share Analysis (%) By Drug Class, 2020 & 2030

Figure 11: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Drug Class, 2020–2030

Figure 12: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020–2030

Figure 13: Global Sinus Therapeutic Drug Market Share Analysis (%) By Disease Type, 2020 & 2030

Figure 14: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Disease Type, 2020–2030

Figure 15: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020–2030

Figure 16: Global Sinus Therapeutic Drug Market Share Analysis (%) By Route of Administration, 2020 & 2030

Figure 17: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Route of Administration, 2020–2030

Figure 18: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020–2030

Figure 19: Global Sinus Therapeutic Drug Market Share Analysis (%) By Distribution Channel, 2020 & 2030

Figure 20: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Distribution Channel, 2020–2030

Figure 21: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020–2030

Figure 22: Global Sinus Therapeutic Drug Market Share Analysis (%) By Region, 2020 & 2030

Figure 23: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Region, 2020–2030

Figure 24: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Region, 2020–2030

Figure 25: North America Sinus Therapeutic Drug Market Value Analysis, 2015–2019

Figure 26: North America Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030

Figure 27: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030

Figure 28: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 29: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030

Figure 30: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030

Figure 31: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 32: Latin America Sinus Therapeutic Drug Market Value Analysis, 2015–2019

Figure 33: Latin America Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030

Figure 34: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030

Figure 35: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 36: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030

Figure 37: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030

Figure 38: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 39: Europe Sinus Therapeutic Drug Market Value Analysis, 2015–2019

Figure 40: Europe Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030

Figure 41: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030

Figure 42: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 43: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030

Figure 44: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030

Figure 45: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 46: South Asia Sinus Therapeutic Drug Market Value Analysis, 2015–2019

Figure 47: South Asia Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030

Figure 48: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030

Figure 49: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 50: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030

Figure 51: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030

Figure 52: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 53: East Asia Sinus Therapeutic Drug Market Value Analysis, 2015–2019

Figure 54: East Asia Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030

Figure 55: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030

Figure 56: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 57: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030

Figure 58: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030

Figure 59: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 60: Oceania Sinus Therapeutic Drug Market Value Analysis, 2015–2019

Figure 61: Oceania Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030

Figure 62: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030

Figure 63: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 64: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030

Figure 65: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030

Figure 66: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 67: MEA Sinus Therapeutic Drug Market Value Analysis, 2015–2019

Figure 68: MEA Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030

Figure 69: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030

Figure 70: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 71: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030

Figure 72: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030

Figure 73: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 74: US Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 75: US Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 76: US Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 77: US Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 78: Canada Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 79: Canada Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 80: Canada Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 81: Canada Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 82: Brazil Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 83: Brazil Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 84: Brazil Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 85: Brazil Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 86: Mexico Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 87: Mexico Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 88: Mexico Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 89: Mexico Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 90: Germany Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 91: Germany Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 92: Germany Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 93: Germany Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 94: Italy Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 95: Italy Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 96: Italy Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 97: Italy Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 98: France Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 99: France Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 100: France Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 101: France Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 102: U.K. Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 103: U.K. Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 104: U.K. Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 105: U.K. Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 106: Spain Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 107: Spain Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 108: Spain Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 109: Spain Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 110: BENELUX Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 111: BENELUX Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 112: BENELUX Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 113: BENELUX Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 114: Russia Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 115: Russia Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 116: Russia Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 117: Russia Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 118: China Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 119: China Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 120: China Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 121: China Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 122: Japan Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 123: Japan Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 124: Japan Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 125: Japan Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 126: South Korea Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 127: South Korea Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 128: South Korea Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 129: South Korea Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 130: India Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 131: India Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 132: India Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 133: India Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 134: Australia Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 135: Australia Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 136: Australia Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 137: Australia Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 138: New Zealand Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 139: New Zealand Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 140: New Zealand Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 141: New Zealand Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 142: GCC Countries Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 143: GCC Countries Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 144: GCC Countries Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 145: GCC Countries Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 146: South Africa Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 147: South Africa Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 148: South Africa Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 149: South Africa Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Figure 150: Turkey Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)

Figure 151: Turkey Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)

Figure 152: Turkey Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)

Figure 153: Turkey Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Sinus Therapeutic Drugs Market